Progenity to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference

January 3, 2022 sandiegobiotech News Comments Off on Progenity to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference

SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that the company will participate in a pre-recorded presentation at the H.C. Wainwright BIOCONNECT Virtual Conference. The presentation will be available on the conference website beginning at 7 a.m. Eastern / 4 a.m. Pacific on January 10, 2022.

Click here to view original post

Related Articles

No Picture
News

Progenity Announces Acceptance of Two Abstracts on Treatment of Gastrointestinal Disorders at ECCO’22

January 5, 2022 sandiegobiotech News Comments Off on Progenity Announces Acceptance of Two Abstracts on Treatment of Gastrointestinal Disorders at ECCO’22

SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that two presentations with patient data on indicators of efficacy in the treatment of gastrointestinal disorders… Click here to view original post… […]

No Picture
News

Progenity Announces Pricing of $40 Million Public Offering of Common Stock and Warrants

August 19, 2021 sandiegobiotech News Comments Off on Progenity Announces Pricing of $40 Million Public Offering of Common Stock and Warrants

SAN DIEGO, Aug. 19, 2021 (GLOBE NEWSWIRE) — Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced the pricing of its previously announced underwritten public offering of 40,000,000 shares of its common stock and warrants to purchase up to 40,000,000 shares of its common stock. Each share… Click here to view original post… […]

No Picture
News

Progenity Announces Closing of $40 Million Underwritten Public Offering

August 24, 2021 sandiegobiotech News Comments Off on Progenity Announces Closing of $40 Million Underwritten Public Offering

SAN DIEGO, Aug. 24, 2021 (GLOBE NEWSWIRE) — Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced the closing of its previously announced underwritten public offering of 40,000,000 shares of its common stock and warrants to purchase up to 40,000,000 shares of its common stock, at a… Click here to view original post… […]